The effect of prostaglandins (PGA 1 and PGB 2 ) on the replication of Mayaro virus was studied in Vero cells. PGA 1 and PGB 2 antiviral activity was found to be dose-dependent. However, while 10 µg/ml PGB 2 inhibited virus yield by 60%, at the same dose PGA 1 suppressed virus replication by more than 90%. SDS-PAGE analysis of [ 35 S]-methionine-labelled proteins showed that PGA 1 did not alter cellular protein synthesis. In infected cells, PGA 1 slightly inhibited the synthesis of protein C, while drastically inhibiting the synthesis of glycoproteins E 1 and E 2 .
Prostaglandins (PGs) are a class of naturally occurring cyclic 20 carbon fatty acids, synthesized from polyunsaturated fatty acid precursors by most eukaryotic cells. These compounds have been shown to function as microenvironmental hormones and intracellular signal mediators and to participate in the regulation of a large variety of physiological and pathological processes (1) .
Prostaglandins inhibit viral replication in cultured cells, but different types of prostaglandins produce different effects on viral replication in several virus-host systems. As with other aspects of prostaglandin action, their antiviral effects are dependent on dose and structure of the cyclopentane ring, and vary for different types of viruses and host cells (2) . Viral transformation has been shown to affect prostaglandin biosynthesis in cultured cells, either increasing or decreasing it, depending on the cell type (3) . Prostaglandins of the E series (PGE) were shown to inhibit the production of parainfluenza 3 virus in WISH cells (4) , and to decrease the yield of measles virus in Vero cells (5) . On the other hand, PGE and PGF increased the size of plaques and the yield of herpes simplex virus in Vero cells (6) . PGs of the A series are potent inhibitors of virus replication in three different systems: Sendai virus in African green monkey kidney cells (7), and vaccinia virus and vesicular stomatitis virus in mouse fibroblast cells (8) .
Mayaro virus (genus Alphavirus, family Togaviridae) is an arthropod-borne virus antigenically related to Semliki Forest virus (9) . Mayaro virus, like other Togaviridae, is perpetuated in nature by its ability to infect and replicate both in vertebrate and invertebrate cells (10, 11) . In Brazil, this virus has been isolated from human and other mammalian species in the Amazon region. Clinical manifestations of human infection were described as a feverish illness, followed by headache, epigastric pain, backache, chills, nausea and photophobia (9) .
Previous results from our laboratory (12) showed that six viral proteins could be de-tected in Mayaro virus-infected BHK-21 cells and Aedes albopictus cells. Three of them are the structural proteins P 1 (54 kDa), P 2 (50 kDa) and P 3 (34 kDa) and the other three are precursors of the viral structural proteins, with molecular weights of 110 kDa, 64 kDa and 62 kDa. By analogy with other alphaviruses, P 1 and P 2 correspond to the glycoproteins E 1 and E 2 , and P 3 corresponds to the non-glycosylated capsid protein (C protein). In the present report, we describe the effect of PGA 1 and PGB 2 on the replication of Mayaro virus in Vero cells assessed by their effects on viral protein synthesis. Possible mechanisms of this antiviral action were investigated.
Vero cells were grown in Dulbecco's modified Eagle's medium (DMEM, Life Technologies, Grand Island, NY) supplemented with 8% calf serum and antibiotics, at 37 o C in a 5% CO 2 atmosphere. PGA 1 and PGB 2 (Sigma Chemical Co., St. Louis, MO) were stored as a stock solution (1 mg/ml) in absolute ethanol and were diluted to the indicated concentrations. Control medium contained the same concentration of ethanol diluent (0.02%) which did not affect cell growth or virus replication. Mayaro virus was obtained from the American Type Culture Collection, Rockville, MD. The virus stock was prepared in BHK-21 cells and stored at -70 o C. Virus titrations were performed by plaque assay in Vero cells. Briefly, a virus dilution (0.5 ml) was added to confluent cell monolayers on 60-mm diameter Petri dishes. After 60 min at 37 o C, unadsorbed virus was removed by aspiration and the monolayers were overlaid with 4 ml of growth medium supplemented with 10% fetal bovine serum and 0.95% agar Noble (Difco Laboratories, Detroit, MI) and were incubated in 5% CO 2 at 37 o C. Two days later, the monolayers were stained with neutral red (25 µg/ml) and the virus plaques counted.
For the protein synthesis studies, confluent cell monolayers were labelled with [ 35 S]-methionine (20 µCi/ml) in methionine-free medium. After labelling, cells were washed and lysed in lysis buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 5% 2-mercaptoethanol and 0.001% bromophenol blue). Samples were then heated for 5 min at 95 o C and subjected to electrophoresis on one-dimensional 12.5% polyacrylamide gels, using the SDS buffer system of Laemmli (13) at room temperature. The dried gels were exposed to Kodak X-Omat (YAR-S) film. The molecular mass of the protein was determined by co-electrophoresis of standard proteins (Pharmacia, Uppsala, Sweden). Protein sythesis was quantitated by densitometric analysis of autoradiographic patterns using a laser-beam densitometer (Ultroscan 2202, LKB Instruments, Bromma, Sweden) and measuring the area of each peak. Each virus protein as measured by the densitometric analysis is reported as a percentage of total virus proteins.
The antiviral effects of PGA 1 and PGB 2 on the growth of Mayaro virus were measured in Vero cells by the plaque reduction assay. None of the compounds tested were toxic to the cells at the concentrations used, as demonstrated by the absence of a cytopathic effect or by vital dye exclusion. PGs were administered after a 1-h period of infection, and culture medium was not changed during the following 24 h. A PG dose-re- sponse curve is shown in Figure 1 . Figure 2 (lanes A, B, C and D) shows that PGA 1 did not alter the pattern of protein synthesis in uninfected cells. In Mayaro virus-infected cells (lanes E, F, G and H) there was a strong inhibition of cellular protein synthesis and all the viral proteins were clearly distinguished. We also observed that PGA 1 produced inhibition of virus protein synthesis. Densitometric analysis of the autoradiogram revealed that the C protein synthesis was moderately inhibited (15%) even at a concentration of 10 µg/ml, which inhibited virus production by more than 90% (Figure 1 ). The synthesis of glycoproteins E 1 and E 2 was by far the most strongly inhibited among all viral proteins. At a concentration of 10 µg/ml, PGA 1 inhibited the synthesis of E 1 and E 2 by more than 50%. Differences in potency between PGA 1 and PGB 2 were also reported for vesicular stomatitis virus-infected L-1210 mouse cells (14) and for human immunodeficiency virus-infected human T cell line C8188 (15). Santoro et al. (16) reported that type A prostaglandins potently inhibit the replication of Sendai virus and can prevent the establishment of a persistent infection by this virus in the African green monkey kidney (AGMK) cell line 37 RC. Later, it was shown that a long-acting synthetic analog of PGA 2 (16, 16-dimethyl-PGA 2 methyl ester) and PGJ 2 can suppress influenza A virus replication in mice (17) .
Several reports have indicated that PG antiviral activity is associated with specific alterations in the synthesis or maturation of specific virus proteins (1). Santoro et al. (7) showed that PGA 1 (4 µg/ml) inhibited the replication of vaccinia virus by 95% and that the antiviral activity was dependent on the presence of PGA 1 during the early stages of infection. PGA 1 partially inhibited vaccinia virus DNA synthesis and altered both the rate and pattern of virus protein synthesis. Subsequently, Santoro et al. (18) found that PGA 1 strongly suppressed the synthesis of vesicular stomatitis virus glycoprotein G and changed the mobility of this protein in SDS-PAGE. The action of PGA 1 on Sendai virus replication has also been found to be associated with specific alterations in virus proteins. While the non-glycosylated viral polypeptides P, NP and M were normally synthesized in PGA 1 -treated cells, the viral glycoproteins HN and Fo were not detected (16) . The authors also showed that PGA 1 -induced alterations in the HN protein caused a loss of its biological function and prevented the insertion of this protein into the cell membrane, thereby blocking virus maturation.
Our results show that a considerable amount of C protein was synthesized in the presence of PGA 1 at a dose that suppressed virus production by more than 90%. However, the inhibition of glycoproteins E 1 and E 2 by more than 50% probably induced modifications in the viral replications cycle, resulting in a decrease of infectious particles. On the other hand, the addition of PGA 1 during a late phase (5 h) still resulted in inhibition of virus production. This suggests that PGA 1 could also act by blocking a late event in virus maturation or assembly.
Data from the literature are still insufficient to identify a mechanism of action of Pgs as antiviral agents, although recent investigations have shown that the antiviral activity of Pgs is associated with the induction of 70-kDa heat shock proteins synthesis (19) . We have previously observed that PGA 1 not only inhibits the replication of Mayaro virus in A. albopictus cells, but also stimulates the synthesis of several cellular polypeptides with molecular weights of 70, 57 and 23 kDa (20) .
In the present study, we have extended the observation that PGA 1 and PGB 2 inhibit the replication of Mayaro virus to yet another cell type, the Vero cell line, in a dosedependent manner and have suggested that this effect occurs simultaneously with a decrease in the synthesis of viral proteins E and, to a lesser extent, C.
